Comparison study of leading targeted therapies for ALK+ lung cancer could lead to better treatment decisions
A team of researchers from the Keck School of Medicine of USC, the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and the USC Shaeffer Center for Health Policy & Economics have conducted a head-to-head ...
10 hours ago
0
1









